Hepatic retinaldehyde deficiency is involved in diabetes deterioration by enhancing PCK1- and G6PC-mediated gluconeogenesis
Type 2 diabetes (T2D) is often accompanied with an induction of retinaldehyde dehydrogenase 1 (RALDH1 or ALDH1A1) expression and a consequent decrease in hepatic retinaldehyde (Rald) levels. However, the role of hepatic Rald deficiency in T2D progression remains unclear. In this study, we demonstrat...
Main Authors: | Hanyu Yang, Mengxiang Su, Ming Liu, Yun Sheng, Liang Zhu, Lu Yang, Ruijing Mu, Jianjun Zou, Xiaodong Liu, Li Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-09-01
|
Series: | Acta Pharmaceutica Sinica B |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383523002319 |
Similar Items
-
Retinaldehyde Dehydrogenase Inhibition-Related Adverse Outcome Pathway: Potential Risk of Retinoic Acid Synthesis Inhibition during Embryogenesis
by: Kichul Cho, et al.
Published: (2021-10-01) -
Natural Retinol Analogs Potentiate the Effects of Retinal on Aged and Photodamaged Skin: Results from In Vitro to Clinical Studies
by: Anthony Brown, et al.
Published: (2023-08-01) -
Microbial Production of Bioactive Retinoic Acid Using Metabolically Engineered <i>Escherichia coli</i>
by: Minjae Han, et al.
Published: (2021-07-01) -
Senotherapeutic Effect of Retinaldehyde and Hyaluronate Fragments in Dermatoporosis
by: Aysin Kaya, et al.
Published: (2023-06-01) -
Retinoid Synthesis Regulation by Retinal Cells in Health and Disease
by: Massimiliano Andreazzoli, et al.
Published: (2024-05-01)